arrow_back Back to App

Transfer of Civil Penalties to Pediatric Research Funding

This act requires civil monetary sanctions collected from specific entities in the pharmaceutical, medical device, dietary supplement, and cosmetic sectors to be transferred to the Pediatric Research Initiative Fund. These funds are designated to support research on pediatric cancer and other childhood diseases at the National Institutes of Health (NIH). The bill also mandates the NIH Director to coordinate research and prioritize projects that do not duplicate existing activities.
Key points
Redirects civil penalties from drug, supplement, and cosmetic manufacturers to a research fund.
Funds research into pediatric cancer and diseases at the NIH.
Requires prioritization of research that avoids duplicating existing NIH activities.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_S_1521
Sponsor: Sen. Kaine, Tim [D-VA]
Process start date: 2021-04-29
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-3-pro-preview
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Gabriella Miller Kids First Research Act 2.0

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_S_1521.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2021-04-29.

What are the main provisions?

Key points include:

  • Redirects civil penalties from drug, supplement, and cosmetic manufacturers to a research fund.
  • Funds research into pediatric cancer and diseases at the NIH.
  • Requires prioritization of research that avoids duplicating existing NIH activities.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Kaine, Tim [D-VA].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2026-01-02.

CATEGORIES

Health